US Aesthetics Market Summary
Companies such as As per Market Research Future analysis, the US Aesthetics Market Size was estimated at 521.25 USD Million in 2024. The US aesthetics market is projected to grow from 556.43 USD Million in 2025 to 1069.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025 - 2035.
The US Aesthetics Market is primarily driven by rising demand for minimally invasive cosmetic procedures, supported by technological advancements and increasing consumer awareness, as individuals seek safer, quicker treatments that enhance appearance while minimizing downtime and improving overall patient satisfaction.
According to the Centers for Disease Control and Prevention (CDC), over 42% of U.S. adults are affected by obesity, increasing demand for body contouring and aesthetic procedures. This growing population seeking physical appearance improvements is significantly driving adoption of aesthetic treatments across the United States.
Key Market Trends & Highlights
The US aesthetics market is experiencing a transformative shift towards non-invasive and personalized treatments.
- North America dominates with ~70% share, while Europe shows strong growth led by Germany (25%) and France (20%) markets.
- Non-invasive procedures dominate with 62% share, driven by safety, convenience, and minimal recovery time.
- Female segment leads with 68% share, reflecting higher engagement in aesthetic treatments.
- Clinics and medical spas hold 64% share, supported by strong patient trust and service availability.
Market Size & Forecast
| 2024 Market Size | 521.25 (USD Million) |
| 2035 Market Size | 1069.0 (USD Million) |
| CAGR (2025 - 2035) | 6.75% |
Major Players
Companies such as Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Ipsen (FR), Hugel (KR), Medytox (KR), Sientra (US) are some of the major participants in the global market.